BioPharm International
BioPharm International-03-15-2020
Volume: 2020 eBook
Issue: 2
BioPharm International-02-01-2020
Volume: 33
Issue: 2
BioPharm International-02-15-2020
Volume: 2020 eBook
Issue: 1
BioPharm International-01-01-2020
Volume: 33
Issue: 1
BioPharm International-12-15-2019
Volume: 2019 eBook
Issue: 5
BioPharm International-12-01-2019
Volume: 32
Issue: 12
BioPharm International-11-01-2019
Volume: 32
Issue: 11
BioPharm International-10-01-2019
Volume: 32
Issue: 10
BioPharm International-09-01-2019
Volume: 32
Issue: 9
BioPharm International-09-15-2019
Volume: 2019 eBook
Issue: 3
BioPharm International-08-01-2019
Volume: 32
Issue: 8
BioPharm International-07-01-2019
Volume: 32
Issue: 7
BioPharm International-06-01-2019
Volume: 43
Issue: 6
BioPharm International-06-15-2019
Volume: 2019 eBook
Issue: 2
BioPharm International-05-01-2019
Volume: 32
Issue: 5
BioPharm International-04-01-2019
Volume: 32
Issue: 4
BioPharm International-04-15-2019
Volume: 2019 eBook
Issue: 1
BioPharm International-03-01-2019
Volume: 32
Issue: 3
BioPharm International-02-01-2019
Volume: 32
Issue: 2
BioPharm International-01-01-2019
Volume: 32
Issue: 1
BioPharm International-12-01-2018
Volume: 31
Issue: 12
BioPharm International-11-01-2018
Volume: 31
Issue: 11
BioPharm International-10-15-2018
Volume: 2018 eBook
Issue: 3
BioPharm International-10-01-2018
Volume: 31
Issue: 10
BioPharm International-09-01-2018
Volume: 31
Issue: 9
BioPharm International-08-01-2018
Volume: 31
Issue: 8
BioPharm International-07-01-2018
Volume: 31
Issue: 7
BioPharm International-06-01-2018
Volume: 31
Issue: 6
BioPharm International-06-15-2018
Volume: 2018 eBook
Issue: 2
BioPharm International-05-01-2018
Volume: 31
Issue: 5
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5